FTI CONSULTING INC (FCN)
Sector: Industrials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Industrials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for FCN
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| FCN | Chief Executive Officer of Bio-Up | 44 | ["LEADERSHIP","FINANCIALLY LITERATE","SERVICES OR INDUSTRY","LEGAL/LITIGATION EXPERIENCE","OTHER PUBLIC COMPANY BOARD EXPERIENCE","GLOBAL","CYBERSECURITY","Chief Executive Officer of Bio-Up","Executive Vice President and Chief Operating Officer of Cellectis","extensive experience in the consulting services industry","various positions at The Boston Consulting Group including Partner and Managing Director","deep experience in the professional services industry","perspectives on corporate strategy, international operational experience, and the evolving healthcare industry"] | ["Audit","Compensation","Chair of Nominating Committee","Chair"] | 2026 |
Biography sourced from the proxy statement filing.
Elsy Boglioli is the Chief Executive Officer of Bio-Up, a consulting firm providing advisory services to companies in the healthcare technology field, which she founded in 2019. From 2017 to 2019, Ms. Boglioli was Executive Vice President and Chief Operating Officer of Cellectis, a clinical-stage biopharmaceutical company focusing on cell therapies. Ms. Boglioli has extensive experience in the consulting services industry, having been employed by The Boston Consulting Group, a leading business strategy consulting services firm, from 2006 to 2017, and previously holding various positions, including Partner and Managing Director and leader of its biotech-focused business in Europe, and serving as a member of its global Strategy and Biopharma Practice leadership teams. Key Skills and Qualifications In addition to her various Chief Executive Officer roles, Ms. Boglioli brings deep experience in the professional services industry to our Board. Ms. Boglioli also provides perspectives on complex issues relevant to the Company s business, including corporate strategy, international operational experience and the evolving healthcare industry that our Board believes qualifies her to serve as a director. Other Foreign Public Company Directorships and Committees: GenSight Biologics S.A. (Chair of Nominating Committee) Select Current Foreign Non-Public Company Directorships and Committees: Inova.io Metafora Biosystems Treefrog Therapeutics (Chair) Womed Tech